Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Operating Leases (2021 - 2025)

Beauty Health (SKIN) has disclosed Operating Leases for 5 consecutive years, with $14.4 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 9.99% to $14.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.4 million through Dec 2025, down 9.99% year-over-year, with the annual reading at $14.4 million for FY2025, 9.99% down from the prior year.
  • Operating Leases for Q4 2025 was $14.4 million at Beauty Health, up from $10.6 million in the prior quarter.
  • The five-year high for Operating Leases was $17.6 million in Q4 2022, with the low at $8.5 million in Q2 2025.
  • Average Operating Leases over 5 years is $12.2 million, with a median of $12.1 million recorded in 2024.
  • The sharpest move saw Operating Leases plummeted 47.19% in 2023, then surged 71.26% in 2024.
  • Over 5 years, Operating Leases stood at $12.8 million in 2021, then surged by 38.07% to $17.6 million in 2022, then crashed by 47.19% to $9.3 million in 2023, then soared by 71.26% to $16.0 million in 2024, then decreased by 9.99% to $14.4 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $14.4 million, $10.6 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.